Freestone Grove Partners’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-25,521
Closed -$445K 796
2024
Q4
$445K Buy
+25,521
New +$445K 0.01% 396